Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies

Patients with restrictive or hypertrophic cardiomyopathy (RCM/HCM) and congenital heart disease (CHD) do not derive clinical benefit from inotropes and mechanical circulatory support. Concerns were expressed that the new heart allocation system implemented in October 2018 would disadvantage these pa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2021-03, Vol.16 (3), p.e0247789-e0247789
Hauptverfasser:	Chouairi, Fouad, Mullan, Clancy W, Sen, Sounok, Mori, Makoto, Fuery, Michael, Elder, Robert W, Lesse, Joshua, Norton, Kelsey, Clark, Katherine A, Miller, P Elliott, Mulligan, David, Formica, Richard, Rogers, Joseph G, Jacoby, Daniel, Maulion, Christopher, Anwer, Muhammad, Geirsson, Arnar, Desai, Nihar R, Ahmad, Tariq
Format:	Artikel
Sprache:	eng
Schlagworte:	Biology and Life Sciences Cardiac patients Cardiology Cardiomyopathy Cardiomyopathy, Hypertrophic Cardiovascular diseases Congenital heart disease Congestive heart failure Coronary artery disease Data analysis Demographic aspects Editing Facilitated communication Health care facilities Health risks Heart Heart diseases Heart surgery Heart transplantation Hemodynamics Medicine Medicine and Health Sciences Methodology Patients Population studies Scandals Social aspects Social Sciences Surgery Survival analysis Transplantation Transplants & implants Variables Ventricle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!